Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/99750
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLeow, Min Lien
dc.contributor.authorChin, Christina Hui Lien
dc.contributor.authorYu, Peggy Shuangen
dc.contributor.authorPasunooti, Kalyan Kumaren
dc.contributor.authorTay, Raymond Xu Zhanen
dc.contributor.authorZhang, Daweien
dc.contributor.authorYoon, Ho Supen
dc.contributor.authorLiu, Xue-Weien
dc.date.accessioned2013-11-07T06:59:03Zen
dc.date.accessioned2019-12-06T20:11:01Z-
dc.date.available2013-11-07T06:59:03Zen
dc.date.available2019-12-06T20:11:01Z-
dc.date.copyright2013en
dc.date.issued2013en
dc.identifier.citationLeow, M. L., Chin, C. H. L., Yu, P. S., Pasunooti, K. K., Tay, R. X. Z., Zhang, D., et al. (2013). Benzofuran-based estrogen receptor α modulators as anti-cancer therapeutics : in silico and experimental studies. Current medicinal chemistry, 20(22), 2820-2837.en
dc.identifier.issn0929-8673en
dc.identifier.urihttps://hdl.handle.net/10356/99750-
dc.description.abstractIn the search for new estrogen receptor alpha (ERα) modulators, a trial molecular screening was conducted and 5,6-dihydroxybenzofuran was identified as a possible drug target for ERα. The target molecular modelling molecule 1 and a series of 5,6-dihydroxybenzofurans have been synthesized and evaluated for their anti-proliferation activities against MCF-7 and MDA-MB-231 cells. From the SAR studies, potential functional groups have been identified, the two hydroxyl groups at C-5 and C-6 and the phenyl ring at C-2, which showed considerable cytotoxicity in MCF-7 breast cancer cells. In addition, the apoptotic abilities of the compounds have been measured in both MCF-7 ER(+) and MDA-MB-231 ER(-) breast cancer cells. The results demonstrated that our compounds inhibit MCF-7 breast cancer cells via ER(+). These preliminary results provide valuable information towards the identification of important functional groups present on 5,6-dihydroxybenzofuran, which could be a promising scaffold for designing novel ER ligands.en
dc.language.isoenen
dc.relation.ispartofseriesCurrent medicinal chemistryen
dc.subjectDRNTU::Science::Chemistry::Biochemistryen
dc.titleBenzofuran-based estrogen receptor α modulators as anti-cancer therapeutics : in silico and experimental studiesen
dc.typeJournal Articleen
dc.contributor.schoolSchool of Physical and Mathematical Sciencesen
dc.identifier.doi10.2174/0929867311320220007en
item.fulltextNo Fulltext-
item.grantfulltextnone-
Appears in Collections:SPMS Journal Articles

SCOPUSTM   
Citations 50

6
Updated on Nov 27, 2022

Web of ScienceTM
Citations 20

5
Updated on Dec 2, 2022

Page view(s) 20

644
Updated on Dec 5, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.